Zdrowie i gospodarka · 18/12/2017

FDA Releases Draft Guidance on Information Requests and Discipline Review Letters Under GDUFA

The FDA is announcing the availability of a draft guidance for industry on how it will issue and use information requests and discipline review letters during the review of ANDA applications, as required by the Generic Drug User Fee Amendments.